Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 19 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Manipulation of an alternative respiratory pathway in photo-autotrophs
Managing multiple web services on a single device
Server-side connection resource pooling
System and method for producing statistically valid assay means and ranges for quality control materials
Systems, methods, and apparatus to determine physical location and routing within a field of low power beacons
Method for determining a corrected variance representative of the condition of reception of signals representative of symbols
  Randomly Featured Patents
Garment for accomodating medical devices
Compiler apparatus and method for devirtualizing virtual method calls
Image forming apparatus
Mobile communication terminal and recording medium
Method for identifying banknotes origin
Oleophilic molybdenum compound for use in hydroconversion of a hydrocarbon and a method for producing the same
Aqueous dental preparation containing fluoride ions and the use thereof
Graduated intraluminal catheter and methods of use thereof
Heterocyclic inhibitors of MEK and methods of use thereof
Hearing aid including a programmable processor